668 related articles for article (PubMed ID: 29989684)
1. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
[TBL] [Abstract][Full Text] [Related]
2. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683
[TBL] [Abstract][Full Text] [Related]
3. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003.
Shimizu Y; Kodama K; Nishi N; Kasagi F; Suyama A; Soda M; Grant EJ; Sugiyama H; Sakata R; Moriwaki H; Hayashi M; Konda M; Shore RE
BMJ; 2010 Jan; 340():b5349. PubMed ID: 20075151
[TBL] [Abstract][Full Text] [Related]
4. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
[TBL] [Abstract][Full Text] [Related]
5. Selection of reference groups in the Life Span Study of atomic bomb survivors.
French B; Cologne J; Sakata R; Utada M; Preston DL
Eur J Epidemiol; 2017 Dec; 32(12):1055-1063. PubMed ID: 29204903
[TBL] [Abstract][Full Text] [Related]
6. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
[TBL] [Abstract][Full Text] [Related]
7. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
[TBL] [Abstract][Full Text] [Related]
8. Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958-2009.
Brenner AV; Preston DL; Sakata R; Cologne J; Sugiyama H; Utada M; Cahoon EK; Grant E; Mabuchi K; Ozasa K
Radiat Res; 2022 May; 197(5):491-508. PubMed ID: 35213725
[TBL] [Abstract][Full Text] [Related]
9. Hyperparathyroidism among atomic bomb survivors in Hiroshima.
Fujiwara S; Sposto R; Ezaki H; Akiba S; Neriishi K; Kodama K; Hosoda Y; Shimaoka K
Radiat Res; 1992 Jun; 130(3):372-8. PubMed ID: 1594765
[TBL] [Abstract][Full Text] [Related]
10. Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.
Grant EJ; Brenner A; Sugiyama H; Sakata R; Sadakane A; Utada M; Cahoon EK; Milder CM; Soda M; Cullings HM; Preston DL; Mabuchi K; Ozasa K
Radiat Res; 2017 May; 187(5):513-537. PubMed ID: 28319463
[TBL] [Abstract][Full Text] [Related]
11. Effect of radiation dose on the height of atomic bomb survivors: a longitudinal study.
Nakashima E; Fujiwara S; Funamoto S
Radiat Res; 2002 Sep; 158(3):346-51. PubMed ID: 12175312
[TBL] [Abstract][Full Text] [Related]
12. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
13. Japanese Legacy Cohorts: The Life Span Study Atomic Bomb Survivor Cohort and Survivors' Offspring.
Ozasa K; Grant EJ; Kodama K
J Epidemiol; 2018 Apr; 28(4):162-169. PubMed ID: 29553058
[TBL] [Abstract][Full Text] [Related]
14. Age-at-exposure effects on risk estimates for non-cancer mortality in the Japanese atomic bomb survivors.
Zhang W; Muirhead CR; Hunter N
J Radiol Prot; 2005 Dec; 25(4):393-404. PubMed ID: 16340068
[TBL] [Abstract][Full Text] [Related]
15. Rediscovery of an old article reporting that the area around the epicenter in Hiroshima was heavily contaminated with residual radiation, indicating that exposure doses of A-bomb survivors were largely underestimated.
Sutou S
J Radiat Res; 2017 Sep; 58(5):745-754. PubMed ID: 29088449
[TBL] [Abstract][Full Text] [Related]
16. Survival analyses of atomic bomb survivors in Hiroshima Prefecture, Japan, 1968-1982--cancer mortality risk among early entrants.
Matsuura M; Hayakawa N; Shimokata H
Hiroshima J Med Sci; 1995 Jun; 44(2):29-38. PubMed ID: 7591838
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Diabetes in the Atomic Bomb Survivors: 1969-2015.
Tatsukawa Y; Cordova K; Yamada M; Ohishi W; Imaizumi M; Hida A; Sposto R; Sakata R; Fujiwara S; Nakanishi S; Yoneda M
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2148-e2155. PubMed ID: 34918116
[TBL] [Abstract][Full Text] [Related]
18. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
[TBL] [Abstract][Full Text] [Related]
19. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
Preston DL; Shimizu Y; Pierce DA; Suyama A; Mabuchi K
Radiat Res; 2003 Oct; 160(4):381-407. PubMed ID: 12968934
[TBL] [Abstract][Full Text] [Related]
20. Exposure to Atomic Bomb Radiation and Age-Related Macular Degeneration in Later Life: The Hiroshima-Nagasaki Atomic Bomb Survivor Study.
Itakura K; Takahashi I; Nakashima E; Yanagi M; Kawasaki R; Neriishi K; Wang JJ; Wong TY; Hida A; Ohishi W; Kiuchi Y
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5401-6. PubMed ID: 26275137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
